Daniel Loeb Merck & Co., Inc. Transaction History

Third Point LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $193 Million - $220 Million	-2,775,000 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $113 Million - $131 Million	-1,725,000 Reduced 38.33%	2,775,000 $212 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $260 Million - $305 Million	4,500,000 New	4,500,000 $319 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Third Point LLC, based on Form 13F filings with the SEC.

Stay updated on Third Point LLC and Daniel Loeb with notifications on news.